Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Emotion Regulation at the End of Breast Cancer Treatment: A Randomized Controlled Study Assessing the Impact of a Multi-Component Psychological Group Intervention

NCT03336827 is registered in ClinicalTrials.gov with Université Libre de Bruxelles as lead sponsor.

NCT NCT03336827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Emotion Regulation at the End of Breast Cancer Treatment: A Randomized Controlled Study Assessing the Impact of a Multi-Component Psychological Group Intervention
Lead sponsor
Université Libre de Bruxelles
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2017
Completion date
February 28, 2020
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety depression, breast cancer, emotional disturbances, emotional dysfunction, fear of cancer